By slicing and dicing a dataset from 277 million patients at 1,591 hospitals, Epic publishes findings more quickly than ...

The FDA has approved a new drug, zanidatamab, for adults with advanced biliary tract cancer, or BTC. Marketed under the brand name Ziihera, it is a first-of-a-kind treatment for patients with ...

Currently, chemotherapy remains a common treatment for biliary tract cancers, which have a limited survival rate.

The U.S. Food and Drug Administration approved Jazz Pharmaceuticals' drug, zanidatamab-hrii, for the treatment of a type of ...

After years of struggling with alcohol dependence, Shana found a combination of treatment and counseling that works for her.

GlobeNewswire, Health, Pharmaceuticals & Biotechnology, Product / Services Announcement | Ziihera is the first and only dual HER2-targeted bispecific ...

The agency has approved Ziihera for adults with previously treated, unresectable or metastatic HER2-positive biliary tract ...

Symptoms of colon cancer and rectal cancer in people under age 50 include rectal bleeding, abdominal pain, and diarrhea.

The FDA has approved Attruby, a new oral treatment that helps reduce heart-related deaths and hospital visits among adults ...

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne ...

The FDA has received a biologics license application submission for RP1 plus nivolumab in patients with PD-1 ...

Attruby (acoramidis), a near complete TTR stabilizer, has been approved by FDA to reduce cardiovascular death and ...